IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,027,750 | +350.7% | 1,225,000 | +122.7% | 2.74% | +369.7% |
| Q2 2023 | $10,433,500 | +146850.7% | 550,000 | +37.5% | 0.58% | +22.9% |
| Q4 2022 | $7,100 | -99.9% | 400,000 | +18.7% | 0.48% | +295.8% |
| Q1 2021 | $5,406,000 | -92.5% | 337,048 | -78.4% | 0.12% | -93.0% |
| Q4 2020 | $72,193,000 | +25.3% | 1,562,952 | -4.6% | 1.72% | -22.5% |
| Q3 2020 | $57,639,000 | – | 1,637,951 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,717,182 | $139,213,000 | 3.92% |
| Ghost Tree Capital, LLC | 525,000 | $12,784,000 | 3.37% |
| Logos Global Management LP | 625,000 | $15,219,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 350,000 | $8,523,000 | 2.46% |
| BVF INC/IL | 1,088,479 | $26,504,000 | 1.63% |
| Vivo Capital, LLC | 800,000 | $19,480,000 | 1.40% |
| Camber Capital Management LP | 800,000 | $19,480,000 | 1.12% |
| Sio Capital Management, LLC | 152,450 | $3,712,000 | 1.08% |
| Prosight Management, LP | 95,500 | $2,325,000 | 1.00% |
| Parkman Healthcare Partners LLC | 125,125 | $3,047,000 | 0.86% |